Clincosm LogoSign in Get a demo

relapsed aml

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Relapsed AML, Refractory AML Trial in Germany (GEM333)

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Mannheim, Baden-Württemberg, Germany
  • +6 more
Sep 28, 2022

Advanced Solid Tumor, Relapsed AML, Refractory AML Trial in Hong Kong (NEI-01)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Hong Kong, Hong Kong
    The University of Hong Kong Phase I Clinical Trials Centre
May 6, 2022

Relapsed AML, T(8;21), C-KIT Mutation Trial in Tianjin (Dasatinib)

Withdrawn
  • Relapsed AML
  • +2 more
  • Tianjin, Tianjin, China
    HBDH
Mar 19, 2020

Relapsed AML, Refractory AML Trial in Tokyo (AC220)

Completed
  • Relapsed AML
  • Refractory AML
  • Tokyo, Japan
    (unnamed)
Feb 8, 2019